Alcuni studi  pubblicati sulla Biblioteca Nazionale Medica degli Stati Uniti


 

L'effetto dei Triterei nell'olio di spore: Effects of Triterpene 42%

Ganoderma lucidum e i suoi benefici: Potent Medicinal Mushroom with Numerous Health Benefits

Ganoderma lucidum come cura:https://journals.sagepub.com/doi/10.1177/1534735414568721

Antinfiammatorio e antitumore:
http://www.ncbi.nlm.nih.gov/pubmed/17311233

Protezione da radiazioni:
http://www.ncbi.nlm.nih.gov/pubmed/21944902

il Ganoderma e il trattamento delle cellule del cancro:
http://www.profdromercolak.com/wp-content/uploads/2010/07/Effects-oftriterpenesfrom-Ganoderma-lucidum-on-proteinexpres.pdf

Sonno e la regolazione cardiaca:
http://www.ncbi.nlm.nih.gov/pubmed/22207209


 1. Bojana B, Marin B, Zhang JS, et al. Ganoderma Lucidum and its pharmaceuticallyactive compounds. Biotech Ann Rev. 2007;13:265–301. [PubMed] 2. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101–134. [PubMed

3. Lin ZB, Wang PY. The pharmacological study of Ganoderma spores and their active compounds. J Peking Univ (Health Sciences) 2006;38(5):541–547. [PubMed] [Google Scholar]

4. Zhang W, Zeng YS. Progress on the spores of Ganoderma Lucidum. J Chin Intergr Med. 2004;2(6):463–465. [Google Scholar]

5. Chen RY, Yu DQ. Progress on triterpenoids of Ganoderma Lucidum. Acta Pharm Sin. 1990;25(12):940–953. [PubMed

6. Luo J, Lin ZB. Advances of pharmacological effects of triterpenes from Ganoderma Lucidum. Acta Pharm Sin. 2002;37(7):574–578. [PubMed

7. Qiao Y, Yang YK, Dong XC, et al. 13C NMR chemical shifts of Ganoderma triterpenoids: a meta-analysis. Chin J Mag Res. 2005;22(4):437–456. 

8. Cheng CR, Yue QX, Wu ZY, et al. Cytotoxic triterpenoids from Ganoderma Lucidum. Phytochemistry. 2010;71:1579–1585. [PubMed

9. Hou CY, Sun YT, Yan L, et al. Studies on the chemical constituents of the spores from Ganoderma Lucidum. Acta Bot Sin. 1988;30(1):66–70. 

10. Chen RY, Yu DQ. Studies on the triterpenoid constituents of the spores of Ganoderma Lucidum Karst. J Chine Pharm Sci. 1993;2(2):91–96. 

11. Chen RY, Yu DQ. Application of 2D NMR techniques in the structure determination of ganosporelactone A and B. Acta Pharm Sin. 1991;26(6):430–436. [PubMed]

12. Min BS, Nakamura N, Miyashiro H, et al. Triterpenes from the spores of Ganoderma Lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. 1998;46(10):1607–1612. [PubMed

13. Min BS, Gao JJ, Nakamura N, et al. Triterpenes from the spores of Ganoderma Lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull. 1998;48(7):1026–1033. [PubMed

14. Min BS, Gao JJ, Hattori M, et al. Anticomplement activity of triterpenoids from the spores of Ganoderma Lucidum. Planta Med. 2001;67:811–814. [PubMed

15. Zhang CR, Yang SP, Yue JM. Sterols and triterpenoids from the spores of Ganoderma Lucidum. Nat Prod Res. 2008;22(13):1137–1142. [PubMed

16. Zhang XQ, Pang GL, Cheng Y, et al. Chemical constituents of the spores of Ganoderma Lucidum. J Chin Med Mat. 2008;31(1):41–44. [PubMed

17. Liu GT, Bao X, Niu S, et al. Some pharmacological actions of the spores of Ganoderma lucidum and the mycelium of Ganoderma capense (Lloyd) Teng cultivated by submerged fermentation. Chin Med J. 1979;92:469–500. [PubMed

18. Liu QY, Sartippour MR, Brooks MN, et al. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep. 2004;12:659–662. [PubMed

19. Zhu HS, Yang XL, Wang LB, et al. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on Hela cells. Cell Bio Toxicol. 2006;16:201–206. [PubMed

20. Ma L, Wu F, Chen RY. Analysis of triterpene constituents from Ganoderma lucidum. Acta Pharm Sin. 2003;38:50–52. 

21. Sliva D, Sedlak M, Slivova V, et al. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Comple Med. 2003;9:491–497. [PubMed

  
 

.........................